SCHEMBL23740686

SCHEMBL23740686

c1ccc2cc(-c3nc(-c4ccc5ccccc5c4)nc(-c4ccc5c(c4)oc4ccc(-n6c7ccc8ccccc8c7c7c8ccccc8ccc76)cc45)n3)ccc2c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT2 Q8IXJ6 3/20 0.35
SIRT1 Q96EB6 3/20 0.35
CYP1A1 P04798 2/20 0.34
CYP1B1 Q16678 1/20 0.34
ABCG2 Q9UNQ0 4/20 0.34
UTRN P46939 1/20 0.34
TDP1 Q9NUW8 4/20 0.33
PAX8 Q06710 2/20 0.33
NPC1 O15118 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
RAB9A P51151 1/20 0.33
CYP1A2 P05177 1/20 0.33
FYN P06241 1/20 0.33
MAPK3 P27361 1/20 0.33
AHR P35869 1/20 0.33
KDM4E B2RXH2 3/20 0.32
MAPT P10636 3/20 0.32
ALDH1A1 P00352 2/20 0.32
MEN1 O00255 1/20 0.32
ESR1 P03372 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23740674 0.97 ABCG2 (0.36) SIRT2SIRT1CYP1A1CYP1B1ABCG2
SCHEMBL23740394 0.95 SIRT2 (0.33) SIRT2SIRT1CYP1A1CYP1B1ABCG2
SCHEMBL24118917 0.94 CYP1A1 (0.36) CYP1A1CYP1B1ABCG2UTRNTDP1
SCHEMBL21863139 0.93 ABCG2 (0.38) SIRT2SIRT1CYP1A1ABCG2TDP1
SCHEMBL21862712 0.92 ABCG2 (0.38) SIRT2SIRT1CYP1A1ABCG2TDP1
SCHEMBL21863142 0.92 ABCG2 (0.34) SIRT2SIRT1CYP1A1CYP1B1ABCG2
SCHEMBL21740706 0.90 TUBB4A (0.36) SIRT2SIRT1CYP1A1CYP1B1UTRN
SCHEMBL23740496 0.89 CYP1A1 (0.34) CYP1A1CYP1B1ABCG2UTRNTDP1
SCHEMBL23740577 0.88 ABCG2 (0.36) SIRT2SIRT1CYP1A1ABCG2TDP1
SCHEMBL21862719 0.87 ABCG2 (0.38) SIRT2SIRT1CYP1A1CYP1B1ABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210395263-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DIODE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DIODE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT EMITTING DIODE LT MATERIALS CO., LTD. (KR) 2021-12-23 US disclosed
EP-3862353-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DIODE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DIODE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT EMITTING DIODE LT Materials Co., Ltd. (KR) 2021-08-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210395263-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DIODE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DIODE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT EMITTING DIODE ODC1, AOX1, CYP1B1 SIRT2 1060/4885SIRT1 710/4885CYP1A1 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.